Race

Visit number vs Insulin
N Mean StdDev Median Min Max Unknown Total
Baseline 49 17.8 ± 10.3 14.5 4.8 46.0 - 49
9-Month Followup 43 15.5 ± 12.8 11.1 3.5 54.9 - 43
18-Month Followup 39 17.5 ± 18.0 10.9 3.1 89.1 1 40
Randomized treatment arm vs Insulin
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 17.8 ± 10.3 14.5 4.8 46.0 - 49
Laparoscopic Gastric Banding (LGB) 28 17.1 ± 10.1 14.9 5.8 46.0 - 28
Continuous Positive Airway Pressure (CPAP) 21 18.8 ± 10.7 14.5 4.8 45.2 - 21
Randomized treatment arm vs Insulin
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 43 15.5 ± 12.8 11.1 3.5 54.9 - 43
Laparoscopic Gastric Banding (LGB) 25 12.6 ± 10.8 8.5 4.4 54.9 - 25
Continuous Positive Airway Pressure (CPAP) 18 19.6 ± 14.4 17.6 3.5 48.5 - 18
Randomized treatment arm vs Insulin
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 17.5 ± 18.0 10.9 3.1 89.1 1 40
Laparoscopic Gastric Banding (LGB) 23 12.5 ± 9.3 9.1 3.1 39.3 1 24
Continuous Positive Airway Pressure (CPAP) 16 24.7 ± 24.5 16.9 4.0 89.1 - 16
Age of the participant vs Insulin
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 17.8 ± 10.3 14.5 4.8 46.0 - 49
27.0 to 45.0 years 13 19.2 ± 9.7 17.2 7.2 38.3 - 13
46.0 to 50.0 years 12 17.8 ± 11.3 14.2 6.0 46.0 - 12
51.0 to 56.0 years 12 19.7 ± 12.4 17.7 4.8 45.2 - 12
57.0 to 65.0 years 12 14.4 ± 7.8 12.8 5.8 28.6 - 12
Age of the participant vs Insulin
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 43 15.5 ± 12.8 11.1 3.5 54.9 - 43
28.0 to 47.0 years 11 18.3 ± 11.1 16.0 6.4 44.5 - 11
47.0 to 52.0 years 11 14.9 ± 15.0 10.1 3.5 54.9 - 11
52.0 to 58.0 years 11 18.9 ± 15.9 12.1 3.9 48.5 - 11
58.0 to 65.0 years 10 9.5 ± 5.5 6.9 4.4 19.5 - 10
Age of the participant vs Insulin
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 17.5 ± 18.0 10.9 3.1 89.1 1 40
29.0 to 46.0 years 10 21.4 ± 10.9 20.6 5.3 39.3 - 10
47.0 to 52.0 years 10 11.7 ± 8.2 8.5 4.0 26.5 - 10
53.0 to 58.0 years 10 27.6 ± 30.3 13.9 6.9 89.1 - 10
58.0 to 65.0 years 9 8.5 ± 4.4 8.6 3.1 16.1 1 10
Gender of the participant vs Insulin
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 49 17.8 ± 10.3 14.5 4.8 46.0 - 49
Male 28 18.1 ± 10.6 15.7 6.0 46.0 - 28
Female 21 17.4 ± 10.2 14.5 4.8 45.2 - 21
Gender of the participant vs Insulin
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 43 15.5 ± 12.8 11.1 3.5 54.9 - 43
Male 25 17.4 ± 13.8 12.1 3.5 54.9 - 25
Female 18 13.0 ± 11.0 10.3 3.9 48.5 - 18
Gender of the participant vs Insulin
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 39 17.5 ± 18.0 10.9 3.1 89.1 1 40
Male 24 17.8 ± 15.8 12.8 4.0 76.4 1 25
Female 15 17.2 ± 21.7 9.0 3.1 89.1 - 15
Race of the participant vs Insulin
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 46 17.7 ± 10.3 14.9 4.8 46.0 - 46
white 35 16.9 ± 8.6 14.5 4.8 38.3 - 35
american indian or alaska native - - - - - - - -
black or african american 9 21.7 ± 15.8 19.0 5.8 46.0 - 9
asian 2 14.5 ± 3.8 14.5 11.8 17.2 - 2
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -
Race of the participant vs Insulin
9-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 40 15.8 ± 13.2 11.1 3.5 54.9 - 40
white 31 14.3 ± 11.0 10.5 3.9 45.1 - 31
american indian or alaska native - - - - - - - -
black or african american 8 22.9 ± 19.2 18.3 3.5 54.9 - 8
asian 1 6.9 - 6.9 6.9 6.9 - 1
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -
Race of the participant vs Insulin
18-Month Followup
N Mean StdDev Median Min Max Unknown Total
Total 36 17.9 ± 18.7 10.3 3.1 89.1 1 37
white 29 16.3 ± 15.2 9.8 3.1 76.4 - 29
american indian or alaska native - - - - - - - -
black or african american 6 27.3 ± 31.7 20.0 4.0 89.1 1 7
asian 1 9.1 - 9.1 9.1 9.1 - 1
native hawaiian or other pacific islander - - - - - - - -
other - - - - - - - -
multiple - - - - - - - -